These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6861205)

  • 1. Suppression of contact sensitivity and cell-mediated lympholysis by oral administration of hapten is caused by different mechanisms.
    Gautam SC; Battisto JR
    Cell Immunol; 1983 Jun; 78(2):295-304. PubMed ID: 6861205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity.
    Gautam SC; Battisto JR
    J Immunol; 1985 Nov; 135(5):2975-83. PubMed ID: 2413107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population.
    Gautam SC; Chikkala NF; Battisto JR
    Cell Immunol; 1990 Feb; 125(2):437-48. PubMed ID: 2137034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two suppressor cells that together prevent in vivo development of cytolytic T cells to hapten-altered self.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    Cell Immunol; 1984 Aug; 87(1):23-34. PubMed ID: 6234995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function.
    Gautam SC; Battisto JR
    Reg Immunol; 1989; 2(1):33-41. PubMed ID: 2534947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresponsiveness in hapten-specific cytotoxic lymphocytes. III. Influence of H-2 and non-H-2 gene loci on the in vitro trinitrophenyl-specific CTL response following either acute or chronic in vivo treatment with trinitrobenzene sulfonic acid.
    Butler LD; Miller SD; Claman HN; Chiller JM
    Cell Immunol; 1983 Feb; 76(1):94-104. PubMed ID: 6600981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
    Galliaerde V; Desvignes C; Peyron E; Kaiserlian D
    Eur J Immunol; 1995 May; 25(5):1385-90. PubMed ID: 7774642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific suppressor T cells in rats active in the afferent phase of contact hypersensitivity.
    Prop J; Griffiths A; Hutchinson IV; Morris PJ
    Cell Immunol; 1986 Apr; 99(1):73-84. PubMed ID: 2428531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells.
    Desvignes C; Etchart N; Kehren J; Akiba I; Nicolas JF; Kaiserlian D
    J Immunol; 2000 Mar; 164(5):2515-22. PubMed ID: 10679089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced suppression of the efferent phase of contact sensitivity in rats.
    Nanishi F; Battisto JR
    Cell Immunol; 1990 Oct; 130(2):378-88. PubMed ID: 2145078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of delayed-type contact sensitivity in the murine oral mucosa by prior intragastric administration of hapten.
    Ahlfors E; Czerkinsky C
    Scand J Immunol; 1997 Sep; 46(3):268-73. PubMed ID: 9315115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresponsiveness in hapten-specific cytotoxic T lymphocytes. I. Characteristics of tolerance induction in adult mice.
    Butler LD; Miller SD; Claman HN
    J Immunol; 1981 Oct; 127(4):1383-7. PubMed ID: 6168687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated T lymphocyte responses against syngeneic cells modified with amino-reactive hapten (AED-NH2): H-2Dk serves as an element for cell-mediated lympholysis to amino-reactive hapten (AED-NH2)-modified self.
    Mizuochi T; Fujiwara H; Takai Y; Hamaoka T
    J Immunol; 1985 Feb; 134(2):673-6. PubMed ID: 3871213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice.
    Grabbe S; Bhardwaj RS; Mahnke K; Simon MM; Schwarz T; Luger TA
    J Immunol; 1996 Jan; 156(2):473-8. PubMed ID: 8543796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis induced by intratracheal administration of hapten.
    Stein-Streilein J
    J Immunol; 1983 Oct; 131(4):1748-53. PubMed ID: 6578271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of a T suppressor factor (TsF) in contact sensitivity: the T cell target for TsF activity in adoptive transfer of immunity is not effector cell.
    Flood P; Ptak W; Green DR
    J Immunol; 1986 Sep; 137(6):1829-35. PubMed ID: 2943804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression.
    Britz JS; Askenase PW; Ptak W; Steinman RM; Gershon RK
    J Exp Med; 1982 May; 155(5):1344-56. PubMed ID: 6461712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.